Home›Drugs and Medicinal Substances›Era (First Approved)›By Century›21st centuryBrowse By21st centuryThis dimension groups drugs by the era in which they were first approved for use. Wikipedia notes that "as a result of this complex path from discovery to commercialization, partnering has become a standard practice for advancing drug candidates through development pipelines," pipelines that end in an approval dated to a specific era. Browsing by era lets a visitor compare drugs first approved in the same period.Facts21st centurySourcesComments (0)Reader Challenges (0)FactsComparisonUses International ClassificationWell-attestedSourced to the subject's own accountWHO Anatomical Therapeutic Chemical (ATC) Classification System 121st centuryFilter Results64 entriesTreats (Condition)AllAnemia (1)Arthritis (1)Autism (1)Bipolar Disorder (1)COVID-19 (2)Depression (1)Giant cell arteritis (1)Graft-Versus-Host Disease (1)Hidradenitis Suppurativa (1)Insomnia Disorder (1)Obesity (1)Psoriasis (1)Psychomotor agitation (1)Schizophrenia (1)Severe Acute Respiratory Syndrome (1)Thrombotic thrombocytopenic purpura (1)Tourette Syndrome (1)Type 2 Diabetes (1)Uveitis (1)Approval StatusAllApproved (59)Investigational / Clinical Trial (2)Withdrawn (3)ATC ClassAllA: Alimentary Tract and Metabolism (5)B: Blood and Blood Forming Organs (2)J: Antiinfectives for Systemic Use (2)L: Antineoplastic and Immunomodulating Agents (44)N: Nervous System (4)R: Respiratory System (1)S: Sensory Organs (1)V: Various (1)Route of AdministrationAllBuccal (1)Inhalation (1)Intramuscular (1)Intratumoral (2)Intravenous (21)Intravesical (1)Oral (25)Subcutaneous (5)Sublingual (2)WHO Essential MedicineAllComplementary List (3)Core List (1)Show ResultsBrowseCompareSelect all 64Abilify21st centuryAbraxane21st centuryAcetadote21st centuryActemra21st centuryAdalimumab21st centuryAllogeneic processed thymus tissue21st centuryAllogeneic umbilical cord-derived CD34- cells, non-expanded/dorocubicel21st centuryAmivantamab/hyaluronidase21st centuryAnavip21st centuryApadamtase alfa21st centuryApixaban21st centuryAripiprazole21st centuryAxicabtagene ciloleucel21st centuryAzficel-T21st centuryBevacizumab21st centuryBexagliflozin21st centuryBinimetinib21st centuryBrexucabtagene autoleucel21st centuryBrigatinib21st centuryCobimetinib21st centuryDecitabine/cedazuridine21st centuryDonislecel21st centuryEncorafenib21st centuryFavipiravir21st centuryFedratinib21st centuryFerric maltol21st centuryFruquintinib21st centuryIdecabtagene vicleucel21st centuryImatinib21st centuryLifileucel21st centuryLisocabtagene maraleucel21st centuryMelphalan flufenamide21st centuryMotixafortide21st centuryMRNA-128321st centuryNabiximols21st centuryNadofaragene firadenovec21st centuryNiraparib/abiraterone acetate21st centuryOmidubicel21st centuryPanobinostat21st centuryPegunigalsidase alfa21st centuryRadotinib21st centuryRemestemcel21st centuryRevakinagene taroretcel21st centuryRexin G21st centuryRimonabant21st centuryRipretinib21st centuryRucaparib21st centurySacituzumab govitecan21st centurySimnotrelvir/ritonavir21st centurySugemalimab21st centuryTabelecleucel21st centuryTagraxofusp21st centuryTazemetostat21st centuryTeserpaturev21st centuryTetrahydrocannabinol/cannabinol/cannabidiol21st centuryTislelizumab21st centuryTividenofusp alfa21st centuryTivozanib21st centuryTocilizumab21st centuryTrametinib21st centuryTucatinib21st centuryUmbralisib21st centuryVorasidenib21st centuryVusolimogene oderparepvec21st centurySources1. Anatomical Therapeutic Chemical Classification System (Wikipedia)tier 3Wikipedialead paragraphQuote, lead paragraphThe Anatomical Therapeutic Chemical (ATC) Classification System is a drug classification system that classifies the active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.View the SourceComments (0)No comments yet. Be the first to share a thought.Sign in to join the discussion.Reader Challenges (0)No disputes yet. Spotted an error or a better source? Open the first one.Sign in to dispute this or suggest a correction.